Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer

Semin Thromb Hemost. 1991 Jul;17(3):303-12. doi: 10.1055/s-2007-1002624.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms / chemistry*
  • Breast Neoplasms / mortality
  • Female
  • Humans
  • Immunohistochemistry
  • Neoplasm Recurrence, Local / metabolism*
  • Plasminogen Inactivators / analysis*
  • Predictive Value of Tests
  • Prognosis
  • Survival Rate
  • Tissue Plasminogen Activator / analysis*
  • Urokinase-Type Plasminogen Activator / analysis*

Substances

  • Plasminogen Inactivators
  • Tissue Plasminogen Activator
  • Urokinase-Type Plasminogen Activator